In 1955, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) affected more than 300 people at London’s Royal Free hospital.
In 1970, a study attributed the outbreak to “mass hysteria”, from which the “it’s in your head” dogma of ME developed. However, in 2006, Dr Byron Hyde revealed the 1970 study as “totally bogus research”. And, in 2015, Prof Betsy Keller of the Department of Exercise & Sports Sciences at New York’s Ithaca College observed that, given all that had been learned about this condition, “it is intellectually embarrassing to suggest that ME is a psychological illness”.
By 2021, others had reduced ME’s psychological dogma to ashes, citing research showing autoimmunity, a low circulating blood volume and the abnormal function of biopsied muscle fibres.
Now, in his book, Understanding ME/CFS & Strategies for Healing (2025), Irish author Patrick Ussher not only adds compelling insights to the burgeoning evidence base for ME’s physical origins, but also outlines a unifying model for ME, highlighting research towards possible effective treatment.
Beaumont Hospital has NTPF waiting list funding suspended over ‘potential financial irregularities’
Autistic man (23) ‘trapped’ in psychiatric unit for five years as HSE fails to secure accommodation
Ireland saw dramatic improvement in mortality in 20-year period, data shows
An Irish family’s race against time for medication: ‘The boys are living their best life possible and we want to make sure they continue to do so’
The 36-year-old told The Irish Times that, before his ME diagnosis in 2018, “I was a PhD student working on Stoic ethics and a composer of contemporary classical music”.
How did he address this daunting health challenge?
“Initially,” he says, “I was almost totally in the dark about ME. Plenty of research exists, but very little is taught to doctors, which left me navigating the ME landscape alone. But I undertook to read and understand the latest research.”
Ussher’s philosophical background may have enriched his understanding of ME-related science, echoing philosopher Mary Midgley who, in her 1992 book, Science and Salvation, noted that increasing scientific specialisation means that mental maps “are required to show fine detail correctly, less and less are they designed to show the whole territory needed for actual journeys”.
But Ussher’s diligence was rewarded when the evolving mental map of his life-changing illness afforded him a glimpse of “the whole territory” in August 2021: “That’s when I encountered the research of German professors, pharmacologist Klaus Wirth and immunologist/ME researcher Carmen Scheibenbogen. They’ve mapped out a 'unifying model’ of ME, (A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) which makes sense of the interrelationship of the most important pre-existing findings, joining up the dots and demystifying the condition."
He adds: “For ME to make sense as an illness, it cannot be random: it must follow certain physiological laws.”
These physiological laws inform the evolution of Wirth and Scheibenbogen’s unifying model hypothesis, which inter alia considers a key role for autoantibodies against blood flow-related cellular receptors in skeletal muscle and the brain; the mechanisms by which ME patients develop low blood volume and systemic blood hypoperfusion (a reduced amount of blood flow); and the contribution of high muscle sodium and calcium concentrations to mitochondrial dysfunction and muscle-tissue necrosis.
The refinement of Wirth and Scheibenbogen’s unifying model hypothesis has led to a therapeutic concept: a drug called Mitodicure, which is “a novel molecule to treat patients with exertional intolerance and post-exertional malaise (PEM)”. Steps are under way to attract funding for clinical trials.
Mitodicure, says Ussher, “could represent the long-awaited breakthrough treatment for ME and Long Covid. Its mechanism of action will interrupt several key vicious cycles at once, particularly targeting the mechanisms underlying PEM.
“During symptom exacerbations of PEM,” he explains, “most illness mechanisms heighten and intensify. By preventing PEM, Mitodicure could relieve physiological burdens, enabling the body to concentrate its resources on healing.
“Mitodicure is not symptom suppression,” Ussher emphasises, “Prof Wirth considers Mitodicure to represent a potential cure for these illnesses.”
Cautiously optimistic, Ussher suggests that Mitodicure could demystify ME: “If you have a therapeutic based on a certain disease model and it works as hypothesised, the disease model is also validated. The pill can prove the principle. So Mitodicure could offer not only improved quality of life (or better) but could also advance our understanding of ME.”
Although Ussher’s enthusiasm is tempered with an acute awareness of the need for scientific rigour, his approach to science appears sceptical towards the exalted status of stored facts and may align with Mary Midgley’s view that stored facts are “valueless unless you know how to use them, how to connect them with other things, how to understand them”. Ussher’s book represents an interpretative scheme; a vehicle, as he puts it, “for raising awareness of Wirth and Scheibenbogen’s ‘unifying model’ of ME and the potential Mitodicure pill which is based on it”.
[ My daily routine living with . . . chronic fatigue syndromeOpens in new window ]
He wants patients and other interested parties to know that there is a comprehensive explanation for this long-misunderstood illness and that “we urgently need investors to fund Mitodicure. The stakes are too high for trials not to happen.
“Millions worldwide need help now, especially as ME is one of the severest outcomes of Long Covid, and the recent pandemic has resulted in countless more suffering from this disease.”
Some might ascribe Ussher’s determination to make progress against the ravages of ME to the Stoic philosophy that he espouses. However, “The most important influence has been my late mum, Mary Redmond. Her journey with cancer, encapsulated in her book, The Pink Ribbon Path, has given me a path to follow now, albeit imperfectly.
“Equally important to me was her work in founding The Irish Hospice Foundation. She fought for the marginalised in her life. I am trying to do the same.”
